Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+1,97%
1 097,38
+21,25
+1,97%
—1 076,131 079,891 100,771 079,89——
SIXC
Communications
SIXC
Communications
SIXC
-0,72%
602,38
-4,36
-0,72%
—606,74606,74607,90602,03——
SIXE
Energy
SIXE
Energy
SIXE
+0,26%
1 252,07
+3,25
+0,26%
—1 248,821 246,371 255,871 239,08——
SIXI
Industrials
SIXI
Industrials
SIXI
+0,99%
1 741,47
+17,11
+0,99%
—1 724,361 733,021 745,751 727,76——
SIXM
Financials
SIXM
Financials
SIXM
-0,10%
634,97
-0,62
-0,10%
—635,59635,08637,89633,31——
SIXR
Staples
SIXR
Staples
SIXR
+0,62%
848,35
+5,20
+0,62%
—843,15842,50848,63840,85——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,19%
216,70
+0,41
+0,19%
—216,29216,29216,91215,24——
SIXT
Technology
SIXT
Technology
SIXT
+2,36%
3 340,45
+77,04
+2,36%
—3 263,413 296,253 342,973 295,42——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,93%
948,02
+8,78
+0,93%
—939,24941,57948,11939,87——
SIXV
Health care
SIXV
Health care
SIXV
+0,32%
1 467,20
+4,64
+0,32%
—1 462,561 465,031 471,261 459,66——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,52%
2 392,72
+12,32
+0,52%
—2 380,402 394,922 412,132 386,94——
Q1 2026 earnings • released • EPS beat +8,75% • Revenue beat +2,17%
See results
RYAN:NYSE
Ryan Specialty Holdings Inc
USD 30,64
+3,23%
(+0,96) 1D
5 Mei, 13:56:44 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RYAN...
Open
USD 29,51
High
USD 30,96
Low
USD 29,37
Mkt. cap
8,07 mjd
Avg. vol.
2,15 m
Volume
2,18 m
Dividend
1,70%
Quarterly dividend
USD 0,13
Ex dividend date
10 Nov. 2025
P/E ratio
40,01
52-wk high
USD 72,50
52-wk low
USD 29,37
EPS
USD 0,77
Beta
0,68
Shares outstanding
128,67 m
No. of employees
6 k
News stories
From sources across the web
About Ryan Specialty Holdings Inc
CEO-
Employees6,11 k
Founded2010
HeadquartersChicago, Illinois, Verenigde State van Amerika
Sector-
Websiteryanspecialty.com
Last report
30 Apr. 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
0,47/ (0,43 est.)USD
+8,75%beat
Revenue / Estimate
795,23 m/ (778,32 m est.)USD
+2,17%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
840,86 m
739,55 m
738,04 m
795,23 m
Cost of goods sold
474,47 m
429,39 m
419,33 m
495,18 m
Cost of revenue
474,47 m
429,39 m
419,33 m
495,18 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
93,35 m
101,83 m
104,97 m
108,76 m
Operating expense
165,91 m
175,62 m
178,51 m
178,16 m
Total operating expenses
640,37 m
605,01 m
597,84 m
673,34 m
Operating income
200,48 m
134,54 m
140,20 m
121,89 m
Other non operating income
-
-
-6,26 m
711,00 k
EBT including unusual items
137,73 m
59,81 m
44,61 m
47,10 m
EBT excluding unusual items
161,62 m
98,18 m
115,14 m
74,40 m
Income tax expense
13,03 m
-2,80 m
13,37 m
6,51 m
Effective tax rate
9,46%
-4,68%
29,97%
13,82%
Other operating expenses
-
-
-
-
Net income
51,98 m
31,08 m
7,98 m
40,60 m
Net profit margin
6,18%
4,20%
1,08%
5,11%
Earnings per share
0,66
0,47
0,45
0,47
Interest and investment income
14,31 m
15,02 m
20,77 m
-
Interest expense
-58,33 m
-56,34 m
-45,75 m
-53,73 m
Net interest expenses
-44,02 m
-41,32 m
-24,98 m
-53,73 m
Depreciation and amortization charges
2,89 m
3,61 m
3,96 m
4,06 m
EBITDA
273,04 m
208,34 m
213,74 m
191,29 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer